Consistent with the newly discovered oncogenic role of AURKA in the signaling axis connecting TOB1-SMAD4 with the CTNNB signaling pathway, we determined that the AURKA gene was highly amplified in human clinical cancer samples across a variety of cancer types in TCGA (The Cancer Genome Atlas) database (Figure 3A). Here, SMAD4 is linked to cancer.